Sabah woman sues KJ, govt over wrongful Covid-19 enforcement
Naomi @ Neomi Francis filed the suit at the Sessions Court in Kota Kinabalu on Wednesday (June 11).
This is believed to be the first known civil suit in Sabah relating to Covid-19 enforcement, raising questions over administrative overreach and alleged infringement of personal rights.
The 59-year-old named the Ranau District Council, the Health Ministry and Khairy in his former capacity as health minister, a post he held from August 2021 to November 2022, as defendants in the suit.
Francis, who operates a stall at the Ranau Central Market, claims she suffered financial losses, reputational harm and psychological trauma after being issued a compound notice on Dec 20, 2021.
She said the compound notice was issued on grounds that she had continued to operate her business without receiving a Covid-19 vaccination.
In her statement of claim, Francis said she felt compelled to receive the vaccine simply to keep her business afloat.
'I was pressured to obtain vaccination solely for the purpose of continuing my business operations,' she said, adding that the ordeal caused her 'significant mental exhaustion, emotional distress and trauma'.
The compound notice was later cancelled by the Health Ministry on Feb 17, 2023.
In an official letter, the ministry's chief enforcement officer acknowledged a technical error in the enforcement action and returned the case to the Sabah State Health Department for review.
The Ranau District Council subsequently retracted the compound notice in a letter dated March 8, 2023.
However, Francis said the damage had already been done. Her stall remained closed from Sept 2021 until March 2023.
'During this time, I lost income, loyal customers, and the public's trust in my business,' she said in the court filing.
She is now seeking specific damages for 18 months of lost earnings, along with general and exemplary damages, interest, and legal costs.
Francis is represented by Messrs Priskila Akwila Advocates.
The court has fixed the hearing for July 14, 2025.
Khairy is now a media personality and co-host of the Keluar Sekejap podcast.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
8 hours ago
- The Star
Hepatitis C treatment can be safely shortened
A new clinical trial conducted in Malaysia has found that an eight-week regimen of ravidasvir and sofosbuvir is just as safe and effective as the standard 12-week treatment for chronic hepatitis C. This finding could accelerate efforts to scale up access to treatment in resource-limited settings by reducing treatment duration, costs and system burden. The EASE study (Evaluating Accelerated Shortened treatment for hepatitis C in Asia through real-world Evidence) was led by the Health Ministry (MOH) and conducted across 26 sites nationwide between March 2021 and March 2023. The randomised trial involved 322 patients diagnosed with chronic hepatitis C virus infection, including those with more complex medical profiles. The primary objective was to determine whether an eight-week treatment course using the fixed-dose combination of ravidasvir and sofosbuvir would achieve similar sustained virological response (SVR), compared to the standard 12-week regimen. An SVR refers to the continued absence of the hepatitis C virus in a patient's blood 12 weeks or more after they have completed treatment. It is essentially considered a virological cure for the infection. The study found no significant difference in efficacy between the two durations, with high SVR rates maintained in both arms. Safety profiles were also comparable, with no new adverse effects identified. The results were officially reported by the MOH in January (2025) and presented at the 2025 European Association for the Study of the Liver (EASL) Congress in early May in Amsterdam, the Netherlands. Ravidasvir was co-developed through a public-health partnership involving the MOH, Drugs for Neglected Diseases initiative (DNDi), Pharco Pharmaceuticals (Egypt) and Pharmaniaga Berhad (Malaysia), with key clinical trials conducted in Malaysia and Thailand. The treatment was first registered in Malaysia in 2021 and added to the World Health Organization (WHO) Essential Medicines List in 2023. While hepatitis C continues to affect approximately 50 million people globally, with only about 20% receiving treatment, high drug prices remain a barrier in many countries. A 2023 MOH study estimates 0.4% of the population in Malaysia to have hepatitis C. In line with WHO targets, Malaysia aims to eliminate the disease as a public health threat by 2030.
Focus Malaysia
17 hours ago
- Focus Malaysia
Malaysia's healthcare travel industry eyes RM12 bil by 2030
MBSB Research recently hosted the Malaysia Healthcare Travel Council (MHTC) in a roundtable dialogue recently. While MHTC focuses on the private healthcare sector, various government ministries, are involved to ensure a cohesive and supportive ecosystem for medical tourism. This multi-agency cooperation is crucial for addressing the diverse needs of the industry, from healthcare standards to visa facilitation and economic planning. Since the decline in Covid-19 prevalence, Malaysia had seen a surge in medical travellers from the Asia-Pacific region seeking treatments. In 2024, the number of medical travellers reached 1.52 mil and revenue at RM2.72 bil. For 2025, MHTC is expecting revenue to climb up to RM3 bil, attributed by a robust demand for quality and affordable care. By 2030, MHTC aims to generate over RM12 bil in revenue, supported by continuous expansion of hospital capacity, targeted promotional efforts and implementation of integrated healthcare. Medical tourism in Malaysia is not just about hospital revenue. It creates a significant ripple effect across the economy. As foreign patients and their companions travel, they spend on various services beyond medical treatments, including accommodation, transportation, dining, and entertainment. This multiplier effect is a critical driver of growth for the hospitality, tourism, and food & beverage sectors. The revenue projected at RM12 bil by 2030 solely accounts for medical-related expenses and excludes the substantial spending on other associated services. This revenue, combined with an estimated economic multiplier of 4x, demonstrates the significant financial benefits of the industry. Every region in Malaysia contributed to medical tourism. In 2024, Central Region contributed 42% of the total revenue (RM886 mil) while Northern Region contributed 41%, Southern Region contributed 12% and the others (East Coast and East Malaysia) contributed 5%. Penang remains a major hub for medical tourism, serving up to 40% of the total volume of medical tourists. Its appeal is driven by its cultural affinity with Mainland Chinese and Indonesians, as well as its strategic proximity, which is supported by high flight frequency. Despite contributing the lowest revenue, East Coast had seen a gain in tourist volumes; likely due to the support from the state tourism and its proximity to Thailand. Meanwhile, Sabah and Sarawak saw high potential for growth, if state hospital brands are well promoted and accessibility by air and land are improved. Malaysia's competitive edge in the regional medical tourism market is its highly regulated healthcare environment. This offers a distinct advantage over competitors like Thailand and attracts patients seeking a safer and more structured treatment setting. Despite the first quarter typically not being a peak period, quarter one of 2025 already recorded a significant 8% increase in revenue (RM631 mil-682 mil) and a 7% rise in traveller volume (370,000-398,000). This indicates that Malaysia still retains an undulated potential and competitiveness in medical tourism. A key advantage for Malaysia is that foreign patients are charged the same rates as locals, which incentivizes them to spend more on other industries like tourism and hospitality. However, regional disparities remain a key challenge. While Penang is a major driver of medical tourism, largely due to key institutions like Island Hospital, East Malaysia struggles to attract medical tourists because of accessibility challenges, limited flight frequency, and less-known hospitals. 'Moving forward, we expect MHTC and other travel-related agencies and sectors (hospitality, consumer and aviation) to improve accessibility, as advocated by the government under the 13th Malaysia Plan,' said MBSB Research. —Aug 6, 2025 Main image: Senior Planet
The Sun
18 hours ago
- The Sun
Melaka strengthens healthcare with RM150k for health programmes
MELAKA: The Melaka government is committed to maintaining a responsive and comprehensive healthcare ecosystem, said Chief Minister Datuk Seri Ab Rauf Yusoh. He said the commitment includes safeguarding the welfare of all frontliners who form the backbone of public well-being. 'As part of ongoing support for improving healthcare services, the state government has allocated RM150,000 specifically for the implementation of health programmes at the state level. 'This initiative also supports the Agenda Nasional Malaysia Sihat (ANMS) for the benefit of the people in the state,' he said at the appreciation and recognition ceremony for Melaka health workers here last night. Also present were state Health, Human Resource and Unity Committee chairman Datuk Ngwe Hee Sem and Health Ministry secretary-general Datuk Seri Suriani Ahmad. Ab Rauf said that as a proactive measure to strengthen the grassroots healthcare network, Melaka has produced a total of 1,369 community paramedic (Parakom) volunteers in collaboration with the Melaka Health Department and St John Ambulance. He added that in efforts to strengthen the state's healthcare ecosystem, the federal government continues to be attentive to the needs and challenges faced by the sector in Melaka. 'For example, the federal government has approved an allocation of RM45.49 million to upgrade healthcare facilities involving 34 health clinics, seven dental clinics, three rural clinics and three hospitals. 'In addition, Melaka will soon have a military hospital worth RM325 million, which is expected to be completed in January 2029 and will have a significant impact on the state's healthcare sector,' he said. A total of 2,000 healthcare workers from various schemes under the state Health Department, as well as staff from four private hospitals in the state, were honoured at the dinner event. - Bernama
